Dr. Ellin Berman

Dr. Ellin Berman, MD, is a highly accomplished hematologist-oncologist at Memorial Sloan Kettering Cancer Center, where she specializes in the diagnosis and treatment of leukemia and other blood cancers. She earned her medical degree from New York Medical College, followed by residency training in internal medicine at Long Island Jewish Medical Center and fellowship in hematology and oncology at Memorial Sloan Kettering. Board-certified in internal medicine, hematology, and medical oncology, Dr. Berman brings decades of experience to her role, offering in-person and telehealth consultations for patients with complex hematologic malignancies.

She is widely respected for her clinical expertise in myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and related disorders. Dr. Berman has been instrumental in developing and conducting clinical trials focused on improving treatments for patients with high-risk leukemias, with a strong emphasis on personalized and targeted therapies. Her research has contributed to understanding the genetic and molecular drivers of blood cancers, and she remains involved in translational initiatives aimed at improving patient outcomes. Dr. Berman frequently presents her findings at national oncology forums and has co-authored numerous peer-reviewed publications in the field.

Beyond her clinical and research accomplishments, Dr. Berman is also a dedicated mentor and educator. She plays a vital role in training hematology/oncology fellows and advancing patient-centered care protocols. Her compassionate, individualized approach and her commitment to integrating the latest scientific insights into everyday clinical practice have earned her recognition among colleagues and patients alike. Through her leadership in leukemia care, commitment to innovation, and dedication to mentorship, Dr. Berman continues to shape the future of hematologic oncology.